Vimarsana
Biggest News Aggregation in the World

Page 10 - Ingle Blind Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ingle Blind Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ingle Blind Study Today - Breaking & Trending Today

Disease Control Elusive for Many Patients on AD Therapies - Vimarsana News

Disease Control Elusive for Many Patients on AD Therapies

A significant number of patients with moderate to severe atopic dermatitis (AD) failed to achieve adequate disease control with systemic therapies over 12 months, indicating a substantial degree of "therapeutic inertia."

FDA Approves Implant for Glaucoma - Vimarsana News

FDA Approves Implant for Glaucoma

An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.

Tafamidis May Help Protect Cardiac Function in ATTR-CM - Vimarsana News

Tafamidis May Help Protect Cardiac Function in ATTR-CM

Patients with transthyretin amyloid cardiomyopathy taking tafamidis have less worsening of cardiac function than those on placebo, post hoc analysis of randomized results suggests.

Is Migraine Really a Female Disorder? - Vimarsana News

Is Migraine Really a Female Disorder?

Migraine is often thought of as a female disorder, but multiple factors make it difficult to determine its true prevalence in women and men.

In Real World, Patients With Myeloma Have Worse Outcomes - Vimarsana News

In Real World, Patients With Myeloma Have Worse Outcomes

A new analysis found that patients with multiple myeloma receiving standard therapies have much worse outcomes compared with those treated in clinical trials.